The Inflation Reduction Act and Access to High-Cost Cardiovascular Therapies

Dhruv S. Kazi,Rishi K. Wadhera,Benjamin N. Rome

JAMA（2023）

引用 0|浏览2

暂无评分

摘要

This Viewpoint discusses how the price negotiation for certain drugs under the Inflation Reduction Act will provide a unique opportunity to enhance access to therapies for older patients with cardiovascular conditions and diabetes.

查看译文

关键词

inflation reduction act,cardiovascular,high-cost

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要